2:50 PM - 2:51 PM
○Kiyoto KASAI (Department of Neuropsychiatry, The University of Tokyo, Japan)
[AsCNP] Symposium
AsCNP » [AsCNP] Symposium
Sun. Oct 13, 2019 2:50 PM - 4:30 PM Room 15 (Palace Room B)
Organizer / Chair: Kiyoto KASAI (Department of Neuropsychiatry, The University of Tokyo, Japan), Co-chair: Jun Soo KWON (Department of Psychiatry, Seoul National University, Korea), Discussants: Yoshiya MORIGUCHI (Medical Affairs, Development Center, Lundbeck Japan), Toshiaki KIKUCHI (Department of Neuropsychiatry, Keio University School of Medicine, Japan)
Recently, international collaborations of studies and research data consortiums have been attracting much attention, not only in genetic research, but also in neuroimaging field in resent years. There are psychosis consortiums such as ENIGMA-SZ, which have been successful to suggest biomarkers for the disorder.
However, as the chronic patients are exposed to medications, reduced social activity and other secondary effects of the disorder for a long time, the consortiums of chronic patients have a critical limitation of not being able to attribute the findings solely to the effect of the disorder.
Therefore, the consortium for the first episode psychosis patients (FEP) is needed to resolve this issue. Asian Consortium on MRI studies in Psychosis (ACMP) is a FEP MRI consortium among the Asian countries. ACMP project plans to collect existing FEP MRI data along with the demographic and clinical information from each participating site to investigate the early changes attributed to the disorder not to the secondary effects such as medication. Longitudinal data collection of FEP is also planned for the investigation of changes along the disorder progression.
In this symposium, each presenter would briefly go through their own hypotheses, based on their previous results and present a preliminary data from ACMP highlighting the strength of ACMP in achieving a common goal of further investigating the core changes of psychosis.
2:50 PM - 2:51 PM
○Kiyoto KASAI (Department of Neuropsychiatry, The University of Tokyo, Japan)
2:51 PM - 3:14 PM
○Shinsuke KOIKE1, 2, 3, 4 (1. Center for Evolutionary Cognitive Sciences, The University of Tokyo, Tokyo, Japan, 2. University of Tokyo Institute for Diversity & Adaptation of Human Mind (UTIDAHM), Tokyo, Japan, 3. The International Research Center for Neurointelligence (WPI-IRCN), Institutes for Advanced Study (UTIAS), The University of Tokyo, Tokyo, Japan, 4. University of Tokyo Center for Integrative Science of Human Behavior (CiSHuB), Tokyo, Japan)
3:14 PM - 3:37 PM
○Su LUI1, Li YAO1, Jieke LIU2, Fei LI1, Wei LIAO4, Wei DENG3, John A SWEENEY5, Qiyong GONG1 (1. Huaxi MR Research Center(HMRRC), Department of Radiology, West China Hospital of Sichuan University, China, 2. Department of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, China, 3. Department of Psychiatry, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, China, 4. Center for Information in BioMedicine, Key Laboratory for Neuroinformation of Ministry of Education, School of Life Science and Technology, University of Electronic Science and Technology of China, China, 5. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, USA)
3:37 PM - 4:00 PM
○Juan Helen ZHOU1, Jimmy LEE2 (1. Duke-National University of Singapore Medical School, Singapore, 2. Institute of Mental Health, Singapore)
4:00 PM - 4:23 PM
○Kang Ik Kevin CHO1, Yoo Bin KWAK1, Wu Jeong HWANG1, Jun Soo KWON1, 2 (1. Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Korea, 2. Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea.)
4:23 PM - 4:29 PM
4:29 PM - 4:30 PM
○Jun Soo KWON (Department of Psychiatry, Seoul National University, Korea)